SLC3A2 and colorectal carcinoma: To investigate the potential role of DRGs in CRC progression, 10 DRGs (GYS1, NDUFS1, NDUFA11, OXSM, LRPPRC, NUBPL, NCKAP1, RPN1, SLC3A2, and SLC7A11) were obtained from Liu’s study (10).